By MICHAEL J. de la MERCED
The venture capital firm has raised $200 million for a new fund devoted to start-ups at the intersection of biology and software.
Published: November 18, 2015 at 07:00PM
from NYT Business Day http://ift.tt/1X7FvMv
from WordPress http://ift.tt/1SYlXtr
No comments:
Post a Comment